MagicMed

Scientists are Using AI to Develop New Psychedelic Drugs

In the News 27 April 2021

While research is still in the early stages, scientists are making massive advancements by deploying artificial intelligence and machine learning to sift through hundreds of millions of different drugs, analogs and derivatives of psychedelics.

Usually drug companies focus on developing one drug for one condition at a time. But using advanced computer science, some researchers are instead developing dozens of potential psychedelics—or drugs that resemble them—all at once.

Read all